Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by langostaon Feb 06, 2018 9:47am

137 Views

Post# 27510119

RE:RE:Looks like we're about to get comfortable..

MathE9 wrote: What's becoming quite obvious, is that NOBODY in the industry really believes this technology will actually work. How else does one truely explain a SP less than $0.20 for a company in P1? If there was even a chance this could actually work, as big Pharma, why wouldn't you take a chance on a JV. It would be stupid not too.

The deafening silence from management merely seems to confirm what the industry believes. It is time for RW to p*ss or get off the pot.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide